Financial statements Neuromedical
Balance sheet of Neuromedical
Company age:
Age:
8 y. 9 m. 29 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of NEUROMEDICAL
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 3 255 083,41 | 2 855 862,61 |
| A. Fixed assets | 3 127 958,66 | 2 502 366,93 |
| B. Current assets | 127 124,75 | 353 495,68 |
| C. Share capital contributions (basic funds) | 0,00 | - |
| D. Own shares (stocks) | 0,00 | - |
| Total liabilities | 3 255 083,41 | 2 855 862,61 |
| A. Equity | 727 124,73 | -189 904,91 |
| B. Liabilities and provisions for liabilities | 2 527 958,68 | 3 045 767,52 |
| I. Long-term liabilities | 894 362,20 | 1 459 507,12 |
| II. Short-term liabilities | 53 987,73 | 68 425,20 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.